2750534-77-9
2750534-77-9
Chemical Structure
Cabotegravir-d5
Synonym(s): GSK-1265744-d5;S/GSK1265744-d5
- CAS No.: 2750534-77-9
- Formula:C19H12D5F2N3O5
- Molecular Weight:410.38
IUPAC Name: (3S,11aR)-N-(2,4-difluorobenzyl)-6-hydroxy-3-(methyl-d3)-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-2,2-d2-8-carboxamide
InChIKey: WCWSTNLSLKSJPK-PXRIRJDNSA-N
SMILES: FC1=C(CNC(C2=CN3C(C(N([C@@H](C([2H])([2H])[2H])C([2H])([2H])O4)[C@@]4([H])C3)=O)=C(O)C2=O)=O)C=CC(F)=C1
Biological Activity: Cabotegravir-d5 is deuterium labeled Cabotegravir.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cabotegravir-d5 | 99.31% | Cabotegravir-d5 is deuterium labeled Cabotegravir. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cabotegravir (Standard) | ≥98% | Cabotegravir (Standard) is the analytical standard of Cabotegravir. This product is intended for research and analytical applications. Cabotegravir (GSK-1265744) is a orally active and long-acting HIV integrase strand transfer inhibitor and organic anion transporter 1/3 (OAT1/OAT3) inhibitor with IC50 values of 2.5 nM, 0.41 μM and 0.81 μM for HIVADA, OAT3 and OAT1, respectively. Cabotegravir is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral agents (ARVs). Cabotegravir can be used to research AIDS. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cabotegravir-d3-1 | Cabotegravir d3-1 (GSK-1265744-d3-1) is a deuterium substitute of Cabotegravir. Cabotegravir is a potent HIV integrase inhibitor used in AIDS research | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cabotegravir-d6 | Cabotegravir-d6 (GSK-1265744-d6) is the deuterium labeled Cabotegravir (HY-15592). Cabotegravir (GSK-1265744) is a orally active and long-acting HIV integrase strand transfer inhibitor and organic anion transporter 1/3 (OAT1/OAT3) inhibitor with IC50 values of 2.5 nM, 0.41 μM and 0.81 μM for HIVADA, OAT3 and OAT1, respectively. Cabotegravir is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral agents (ARVs). Cabotegravir can be used to research AIDS. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cabotegravir | 99.92% | Cabotegravir (GSK-1265744) is a orally active and long-acting HIV integrase strand transfer inhibitor and organic anion transporter 1/3 (OAT1/OAT3) inhibitor with IC50 values of 2.5 nM, 0.41 μM and 0.81 μM for HIVADA, OAT3 and OAT1, respectively. Cabotegravir is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral agents (ARVs). Cabotegravir can be used to research AIDS. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
